The next first-in-class blockbuster drug.
Favorable pricing and reimbursement by government.
Longer patent life.
Orphan drug designations.
Coverage on all formularies.
The next first-in-class blockbuster drug.
Favorable pricing and reimbursement by government.
Longer patent life.
Orphan drug designations.
Coverage on all formularies.